SCHEMBL9114518

SCHEMBL9114518

[CH]=Cc1cccn2ccnc12

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NUDT1 P36639 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.30
DYRK1A Q13627 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9111585 0.81 NUDT1 (0.41) NUDT1L3MBTL1DYRK1A
SCHEMBL2317243 0.81 TRIM24 (0.41) NUDT1L3MBTL1
SCHEMBL9113364 0.78 NUDT1 (0.38) NUDT1
SCHEMBL361103 0.78 NUDT1 (0.38) NUDT1
SCHEMBL31650435 0.78 NUDT1 (0.38) NUDT1L3MBTL1
SCHEMBL9112910 0.74 NUDT1 (0.35) NUDT1
SCHEMBL335977 0.71 NUDT1 (0.58) NUDT1L3MBTL1DYRK1A
SCHEMBL418310 0.71 NUDT1 (0.46) NUDT1L3MBTL1DYRK1A
SCHEMBL259658 0.71 NUDT1 (0.42) NUDT1L3MBTL1
SCHEMBL6370683 0.71 NUDT1 (0.42) NUDT1L3MBTL1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0670831-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-09-13 EP disclosed
WO-1995009159-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1995-04-06 WO disclosed